This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genfit. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David Magrez: Innovator in Pharmaceutical Treatments
Introduction
David Magrez is a notable inventor based in Lambersart, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
David Magrez holds a patent for "Compositions and methods for the treatment of primary biliary cholangitis." This invention relates to a pharmaceutical composition comprising elafibranor or a pharmaceutically acceptable salt thereof, intended for use in treating primary biliary cholangitis (PBC) in subjects who are intolerant to ursodeoxycholic acid (UDCA). This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
David Magrez is associated with Genfit, a company that focuses on developing innovative therapies for liver diseases. His role at Genfit has allowed him to collaborate with other talented professionals in the field, contributing to the company's mission of providing effective treatments for patients.
Collaborations
Some of his notable coworkers include Pascal Birman and Alice Roudot. Their collective expertise enhances the research and development efforts at Genfit, fostering an environment of innovation and collaboration.
Conclusion
David Magrez's contributions to pharmaceutical innovations, particularly in the treatment of primary biliary cholangitis, underscore his role as a leading inventor in the field. His work not only reflects his dedication to medical advancements but also highlights the importance of collaboration in achieving significant breakthroughs.